ZYBT Zhengye Biotechnology Holding Limited

Healthcare

$0.86-1.05%ClosedMarket Cap: $40.8M

As of 2026-05-26

Valuation

P/E (TTM)

—

PEG

—

P/B

0.00

P/S

2.40

EV/EBITDA

-7.15

DCF Value

$1.07

FCF Yield

0.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

20.5%

Operating Margin

-58.7%

Net Margin

-60.0%

ROE

-26.1%

ROA

-16.0%

ROIC

-17.9%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
FY null	$116.4M	20.5%	$-68.3M	$-69.8M	$—	—
FY null	$186.4M	49.0%	$16.4M	$11.3M	$—	—
FY null	$211.7M	61.4%	$45.0M	$31.5M	$—	—
FY null	$260.3M	59.0%	$65.8M	$46.7M	$—	—
FY null	$214.1M	58.6%	$52.4M	$39.0M	$—	—